University of North Carolina, Chapel Hill
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of North Carolina, Chapel Hill sits in the top decile of US sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count).
University of North Carolina, Chapel Hill: 1,109 sponsored US clinical trials, 108 recruiting.
University of North Carolina, Chapel Hill sponsors 1,109 registered US clinical trials on ClinicalTrials.gov, 108 of them currently recruiting, and 881 completed. 69 of these trials are in Phase 3-4 (later-stage) and 203 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of North Carolina, Chapel Hill ranks in the top decile of sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
881 of 962 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,109 total, page 13 of 23
Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection
NCT02384395
Patient Education to Improve Pain Management in Older Adults With Acute Musculoskeletal Pain: A Pilot Randomized Trial
NCT02438384
Chronic Lumbosacral Radiculopathy: Impact of an Analgesic Dietary Intervention on Pain & Function
NCT02531711
19F MRI of Ventilation in Subjects With Cystic Fibrosis Undergoing Treatment for Pulmonary Exacerbation
NCT03497117
Study of Orofacial Pain and PropRANOlol
NCT02437383
Optimizing Drug Doses in Critically Ill
NCT02437838
Transitioning HIV+ Adolescents to Adult Care: Exploring Adolescent and Adult Medicine Clinics Role in the Process
NCT02785302
Health Experiences & Early Life Disadvantages
NCT02400593
Intravenous Exenatide in Patients With Acute Brain Injury
NCT02058940
Autoimmune Paradoxical Reactions in IBD Longitudinal Cohort
NCT02503514
Normalizing HPV Vaccination in Preteens With a Serious Video Game
NCT04627298
19F MRI to Evaluate Regional Ventilation in Healthy Subjects and Subjects With Cystic Fibrosis
NCT03489590
Oxytocin Treatment of Alcohol Dependence
NCT02251912
Emotional Processing and Oxytocin Mechanisms in Premenstrual Dysphoric Disorder: A Pilot Study
NCT02508103
Initial and Chronic Methicillin Resistant Staphylococcus Aureus (MRSA) Infection in Cystic Fibrosis (CF)
NCT02684422
Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying Responders
NCT02476409
Adolescent Vaccination in Pharmacies
NCT01960088
Using Question Prompt Lists During Pediatric Asthma Visits to Increase Adolescent Involvement
NCT02498834
Diagnosis and Monitoring of Eosinophilic Esophagitis Using the Cytosponge
NCT02114606
Testing the Effects of the CDSMP Among Lower-to-Middle Wage Workers
NCT04116463
Acute Partner and Social Contact Referral: iKnow
NCT02467439
Breakfast Meal Replacement
NCT02482545
Assessing the Engagement of Transgender and Other Gender Minority Youth Across the HIV Continuum of Care
NCT02449629
Epic Allies HIV ART Adherence Intervention
NCT02782130
Seeing the World Through Assorted Glasses
NCT02483559
Role of IL-37 Genetic Variants in Modulating Innate Immune Response to Periodontal Pathogens
NCT03161301
Transcranial Alternating Current Stimulation for Major Depressive Disorder
NCT02339285
Video Counseling for Effective Postpartum Contraception
NCT02438800
STimulation to Improve Auditory haLLucinations
NCT02360228
Feasibility of an Interval Exercise and Nutrition Intervention to Reduce Cardiovascular Disease Risk Factors
NCT02482922
Improvement in Wound Healing With Negative Pressure Wound Therapy for Postoperative Total Hip Arthroplasty
NCT02355691
Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy
NCT02208167
Permanent Versus Absorbable Colpopexy Trial
NCT02277925
Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin
NCT02235233
AFIX to Improve HPV Vaccination
NCT02370459
The STRENGTH Study: Shapely Sisters Targeting Realistic Exercise and Nutrition Goals Through Healthy Habits
NCT02253641
Integrated Coping and Awareness Training
NCT02400502
Dose Proportionality of TFV-DP After a Single Dose of GS-7340 in Women
NCT02357602
Our Year of Healthy Living (Formative Research & Intervention)
NCT02330354
PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders
NCT02438592
Making Effective Human Papillomavirus (HPV) Vaccine Recommendations
NCT02377843
Tracking Outcomes in Pain Patients Using Fitness Devices
NCT02420457
Care2BWell: Worksite Wellness for Child Care
NCT02381938
Genetics of Primary Ciliary Dyskinesia
NCT02389049
Does Physical Therapy Prevent Total Knee Arthroplasty in Patients With End Stage Osteoarthritis
NCT02377102
Treprostinil Sodium Inhalation for Patients At High Risk for ARDS
NCT02370095
Detection of Brown Adipose Tissue by Magnetic Resonance Imaging
NCT02237872
Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis
NCT02019758
Social Cognition and Interaction Training for Autism
NCT02382172
Analysis of Procedural Times Using Colpassist for Robotic-Assisted Sacrocolpopexy; a Randomized Controlled Trial
NCT02367235
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 111 |
| Phase 2 | 92 |
| Phase 3 | 13 |
| Phase 4 | 56 |
Therapeutic Areas
What is open in the University of North Carolina, Chapel Hill pipeline
108 recruiting of 1,109 indexed (10% open); 881 completed (79%).
Phase mix: 69 late (III/IV) vs 203 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of North Carolina, Chapel Hill: open-pipeline peers nationwide
Peers matched on 1,109 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
University of North Carolina, Chapel Hill sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,109 trials (± recruiting share)
- University of Florida · 1,106 trials · 15% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Children's Hospitals and Clinics of Minnesota · 10% recruiting · 31 trials
- Cytokinetics · 10% recruiting · 31 trials
- Sanofi · 10% recruiting · 713 trials
- Ohio University · 10% recruiting · 51 trials
Related
What to do with this University of North Carolina, Chapel Hill page
1,109 registered trials is a research-attention snapshot, not an endorsement of University of North Carolina, Chapel Hill or any single study.
- 108 of University of North Carolina, Chapel Hill's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of North Carolina, Chapel Hill studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of North Carolina, Chapel Hill pipeline card: 1,109 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.